scholarly article | Q13442814 |
P2093 | author name string | Miriam Aguilar | |
Araceli Monzón | |||
Isabel Rivera | |||
Piedad Ussetti | |||
Clara Salas | |||
Isabel Sánchez | |||
Aris Pérez | |||
Bárbara Balandin | |||
Miguel Valdivia | |||
Sara Alcántara | |||
P2860 | cites work | EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds | Q56837279 |
Synergy, antagonism, and what the chequerboard puts between them | Q73521098 | ||
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis | Q84510740 | ||
Infections caused by Scedosporium spp. | Q24657691 | ||
Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis | Q34130445 | ||
Evaluation of Sulfobutylether-β-Cyclodextrin Exposure in a Critically Ill Patient Receiving Intravenous Posaconazole While Undergoing Continuous Venovenous Hemofiltration | Q36076106 | ||
Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. | Q36933405 | ||
Fungal infections after lung transplantation | Q37420339 | ||
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology | Q37688257 | ||
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity | Q37860189 | ||
Mold infections in lung transplant recipients | Q38118956 | ||
Nebulized voriconazole in infections with Scedosporium apiospermum--case report and review of the literature | Q38164992 | ||
Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections | Q38321383 | ||
Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification | Q38430959 | ||
Fungal empyema thoracis: an emerging clinical entity. | Q40619981 | ||
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. | Q42227953 | ||
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens | Q42254813 | ||
Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients | Q44599233 | ||
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report | Q46075237 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | lung transplant | Q1637912 |
intensive care unit | Q5094647 | ||
Scedosporium apiospermum | Q54371054 | ||
P304 | page(s) | 53-56 | |
P577 | publication date | 2016-03-01 | |
P1433 | published in | Medical mycology case reports | Q27724618 |
P1476 | title | Scedosporium apiospermum and S. prolificans mixed disseminated infection in a lung transplant recipient: An unusual case of long-term survival with combined systemic and local antifungal therapy in intensive care unit | |
P478 | volume | 11 |
Q46281613 | A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature. |
Q39375883 | Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience. |
Q64084563 | Disseminated central nervous system infection after lung transplantation: A case report with successful recovery |
Q88375368 | Endobronchial Topical Amphotericin B Instillation for Pulmonary Chromomycosis After Lung Transplantation: A Case Report |
Q38668190 | Enzymatic Mechanisms Involved in Evasion of Fungi to the Oxidative Stress: Focus on Scedosporium apiospermum |
Q33797083 | Scedosporium apiospermum brain abscesses in a patient after near-drowning - a case report with 10-year follow-up and a review of the literature |
Search more.